PEIP 2024: Q and A Session 8

Q&A for the following PEIP talks: That Other F-Word: Fibromyalgia and Hot and Bothered? Cooling the Heat in Menopause… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here… Read More

PEIP 2024: Hot and Bothered? Cooling the Heat in Menopause

1. Discuss, using an evidence-based approach, medications used to manage vasomotor symptoms of menopause, including their efficacy and potential side effects. 2. Review and discuss the risks associated with hormone replacement therapy (HRT) for menopause, including long-term health implications and contraindications. 3. Describe and analyze common musculoskeletal and metabolic changes… Read More

PEIP 2024: That Other F-Word: Fibromyalgia

1. Identify patients who may have fibromyalgia and outline an effective diagnostic approach, including key clinical features and diagnostic criteria. 2. Evaluate and discuss evidence-informed treatments for fibromyalgia, focusing on non pharmacological strategies such as sleep hygiene and exercise. 3. Review and analyze evidence-based medical treatments for fibromyalgia, including the… Read More

PEIP 2024: Q and A Session 7

Q&A for the following PEIP talks: Canadian Task Force – Updated 2024 Breast Cancer Guidelines and Aging Wisely: RxFiles Geriatric Pearls… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here… Read More

PEIP 2024: Aging Wisely: RxFiles Geriatric Pearls

1. Discuss and evaluate the risks associated with PPIs in older adults. 2. Clarify the risks and potential harms of using antipsychotic medications in older adults, including their impact on physical health, cognitive function, and overall safety. 3. Identify and recommend 2-3 safer prescribing practices for older adults, focusing on… Read More

Loading...